EcoDrugPlus

Rho-Associated Protein Kinase 2-Like

Ensembl ID : ENSOTSG00005001200
Gene Symbol: LOC112261645
3 Cross references
218 Possible Orthologues:

Ribosomal Protein L11

Ensembl ID : ENSOTSG00005029385
Gene Symbol: RPL11
1 Cross references
282 Possible Orthologues:

Ribosomal Protein L12

Ensembl ID : ENSOTSG00005047672
Gene Symbol: RPL12
3 Cross references
478 Possible Orthologues:

Ribosomal Protein L14

Ensembl ID : ENSOTSG00005015160
Gene Symbol: RPL14
1 Cross references
303 Possible Orthologues:

Ribosomal Protein L15

Ensembl ID : ENSOTSG00005035561
Gene Symbol: RPL15
1 Cross references
352 Possible Orthologues:

Ribosomal Protein L15

Ensembl ID : ENSOTSG00005043691
Gene Symbol: RPL15
1 Cross references
352 Possible Orthologues:

Ribosomal Protein L18

Ensembl ID : ENSOTSG00005015415
Gene Symbol: RPL18
1 Cross references
364 Possible Orthologues:

Ribosomal Protein L18

Ensembl ID : ENSOTSG00005037759
Gene Symbol: RPL18
1 Cross references
365 Possible Orthologues:

Ribosomal Protein L21

Ensembl ID : ENSOTSG00005011679
Gene Symbol: RPL21
3 Cross references
778 Possible Orthologues:

Ribosomal Protein L22

Ensembl ID : ENSOTSG00005027745
Gene Symbol: RPL22
1 Cross references
160 Possible Orthologues:

Ribosomal Protein L22

Ensembl ID : ENSOTSG00005043890
Gene Symbol: RPL22
1 Cross references
204 Possible Orthologues:

Ribosomal Protein L23a

Ensembl ID : ENSOTSG00005040890
Gene Symbol: RPL23A
1 Cross references
209 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).